Harbour Capital Advisors, LLC Eli Lilly & CO Transaction History

Harbour Capital Advisors, LLC

  • $411 Million
  • Q2 2024

A detailed history of Harbour Capital Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Harbour Capital Advisors, LLC holds 18,742 shares of LLY stock, worth $16.6 Million. This represents 4.12% of its overall portfolio holdings.

Number of Shares
18,742
Previous 18,817 0.4%
Holding current value
$16.6 Million
Previous $14.6 Million 15.92%
% of portfolio
4.12%
Previous 3.67%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024
SELL
$724.87 - $909.04 $54,365 - $68,178
-75 Reduced 0.4%
18,742 $17 Million
Q1 2024

Apr 16, 2024
SELL
$592.2 - $792.28 $40,861 - $54,667
-69 Reduced 0.37%
18,817 $14.6 Million
Q4 2023

Jan 05, 2024
BUY
$525.19 - $619.13 $15,230 - $17,954
29 Added 0.15%
18,886 $11 Million
Q3 2023

Oct 05, 2023
BUY
$434.7 - $599.3 $83,027 - $114,466
191 Added 1.02%
18,857 $10.1 Million
Q2 2023

Jul 10, 2023
SELL
$350.74 - $468.98 $101,013 - $135,066
-288 Reduced 1.52%
18,666 $8.75 Million
Q1 2023

Apr 19, 2023
SELL
$310.63 - $364.82 $727,184 - $854,043
-2,341 Reduced 10.99%
18,954 $6.51 Million
Q4 2022

Jan 13, 2023
SELL
$321.55 - $374.67 $213,830 - $249,155
-665 Reduced 3.03%
21,295 $0
Q3 2022

Oct 19, 2022
SELL
$296.48 - $337.87 $8,894 - $10,136
-30 Reduced 0.14%
21,960 $7.11 Million
Q2 2022

Jul 20, 2022
SELL
$278.73 - $327.27 $42,645 - $50,072
-153 Reduced 0.69%
21,990 $7.13 Million
Q1 2022

Apr 11, 2022
SELL
$234.69 - $291.66 $352,504 - $438,073
-1,502 Reduced 6.35%
22,143 $6.34 Million
Q4 2021

Jan 12, 2022
BUY
$224.85 - $279.04 $46,319 - $57,482
206 Added 0.88%
23,645 $6.53 Million
Q3 2021

Oct 13, 2021
BUY
$221.6 - $272.71 $55,843 - $68,722
252 Added 1.09%
23,439 $5.42 Million
Q2 2021

Jul 14, 2021
BUY
$180.55 - $233.54 $5,235 - $6,772
29 Added 0.13%
23,187 $5.32 Million
Q1 2021

Apr 12, 2021
BUY
$164.32 - $212.72 $18,896 - $24,462
115 Added 0.5%
23,158 $4.33 Million
Q4 2020

Jan 12, 2021
BUY
$130.46 - $172.63 $15,785 - $20,888
121 Added 0.53%
23,043 $4,000
Q3 2020

Oct 09, 2020
BUY
$146.22 - $169.13 $75,888 - $87,778
519 Added 2.32%
22,922 $3.39 Million
Q2 2020

Jul 21, 2020
SELL
$136.42 - $164.18 $22,509 - $27,089
-165 Reduced 0.73%
22,403 $3.68 Million
Q1 2020

Apr 08, 2020
SELL
$119.05 - $147.35 $714 - $884
-6 Reduced 0.03%
22,568 $3.13 Million
Q4 2019

Jan 22, 2020
SELL
$106.92 - $132.43 $36,673 - $45,423
-343 Reduced 1.5%
22,574 $2.97 Million
Q3 2019

Oct 30, 2019
BUY
$106.79 - $116.16 $122,381 - $133,119
1,146 Added 5.26%
22,917 $2.56 Million
Q2 2019

Jul 10, 2019
BUY
$110.79 - $129.32 $23,265 - $27,157
210 Added 0.97%
21,771 $2.41 Million
Q1 2019

Apr 24, 2019
SELL
$111.31 - $131.02 $456,259 - $537,050
-4,099 Reduced 15.97%
21,561 $2.8 Million
Q4 2018

Jan 23, 2019
SELL
$105.9 - $118.64 $101,134 - $113,301
-955 Reduced 3.59%
25,660 $2.97 Million
Q3 2018

Nov 07, 2018
SELL
$85.86 - $107.31 $42,071 - $52,581
-490 Reduced 1.81%
26,615 $2.86 Million
Q2 2018

Jul 11, 2018
BUY
$75.7 - $86.88 $98,031 - $112,509
1,295 Added 5.02%
27,105 $2.33 Million
Q1 2018

Apr 18, 2018
BUY
$74.21 - $87.6 $232,796 - $274,801
3,137 Added 13.84%
25,810 $2 Million
Q4 2017

Jan 24, 2018
BUY
$81.94 - $87.89 $50,966 - $54,667
622 Added 2.82%
22,673 $1.92 Million
Q3 2017

Nov 08, 2017
BUY
$77.07 - $85.54 $1.7 Million - $1.89 Million
22,051
22,051 $1.89 Million

Others Institutions Holding LLY

# of Institutions
3,871
Shares Held
751M
Call Options Held
6.34M
Put Options Held
7.97M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $843B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Harbour Capital Advisors, LLC Portfolio

Follow Harbour Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbour Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email